Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-24,418
Closed -$1.23M 3363
2015
Q4
$1.23M Sell
24,418
-20,332
-45% -$1.03M 0.02% 687
2015
Q3
$2.11M Buy
44,750
+26,934
+151% +$1.43M 0.03% 422
2015
Q2
$968K Sell
17,816
-29,030
-62% -$1.63M 0.02% 880
2015
Q1
$2.57M Buy
46,846
+4,926
+12% +$279K 0.05% 282
2014
Q4
$2.27M Sell
41,920
-3,354
-7% -$187K 0.04% 372
2014
Q3
$2.56M Sell
45,274
-58,897
-57% -$3.31M 0.05% 344
2014
Q2
$5.75M Sell
104,171
-35,318
-25% -$1.93M 0.09% 144
2014
Q1
$7.56M Buy
139,489
+68,015
+95% +$3.52M 0.09% 159
2013
Q4
$3.41M Sell
71,474
-25,885
-27% -$1.18M 0.04% 375
2013
Q3
$4.42M Buy
+97,359
New +$4.45M 0.06% 254

Other funds holding MRK

Virtu KCG Holdings's MRK Position: Q2 2017 in Review

Virtu KCG Holdings increased its Merck (MRK) stake by 580% in Q2 2017, buying an estimated $6.68M and bringing the position to 128,662 shares worth $7.87M. The position accounts for 0.22% of the portfolio, ranked #31.

Virtu KCG Holdings first reported a position in MRK in Q3 2013 and has held it in 15 quarters since. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Virtu KCG Holdings held 128,662 shares of Merck worth $7.87M as of Q2 2017.
  • Virtu KCG Holdings bought 109,746 Merck shares in Q2 2017, an estimated $6.68M.
  • Merck made up 0.22% of Virtu KCG Holdings's portfolio in Q2 2017, its #31 holding.
  • Virtu KCG Holdings first reported a position in Merck in Q3 2013 and has held it in 15 quarters since.
  • 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.